IBDEI108 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16338,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16338,1,3,0)
;;=3^Neurogenic Bladder Dysfunction,Unspec
;;^UTILITY(U,$J,358.3,16338,1,4,0)
;;=4^N31.9
;;^UTILITY(U,$J,358.3,16338,2)
;;=^5015648
;;^UTILITY(U,$J,358.3,16339,0)
;;=N31.1^^61^772^80
;;^UTILITY(U,$J,358.3,16339,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16339,1,3,0)
;;=3^Neuropathic Bladder,Reflex NEC
;;^UTILITY(U,$J,358.3,16339,1,4,0)
;;=4^N31.1
;;^UTILITY(U,$J,358.3,16339,2)
;;=^5015645
;;^UTILITY(U,$J,358.3,16340,0)
;;=N32.89^^61^772^7
;;^UTILITY(U,$J,358.3,16340,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16340,1,3,0)
;;=3^Bladder Disorders,Other Spec
;;^UTILITY(U,$J,358.3,16340,1,4,0)
;;=4^N32.89
;;^UTILITY(U,$J,358.3,16340,2)
;;=^87989
;;^UTILITY(U,$J,358.3,16341,0)
;;=N33.^^61^772^6
;;^UTILITY(U,$J,358.3,16341,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16341,1,3,0)
;;=3^Bladder Disorders,Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,16341,1,4,0)
;;=4^N33.
;;^UTILITY(U,$J,358.3,16341,2)
;;=^5015654
;;^UTILITY(U,$J,358.3,16342,0)
;;=N34.2^^61^772^115
;;^UTILITY(U,$J,358.3,16342,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16342,1,3,0)
;;=3^Urethritis
;;^UTILITY(U,$J,358.3,16342,1,4,0)
;;=4^N34.2
;;^UTILITY(U,$J,358.3,16342,2)
;;=^88231
;;^UTILITY(U,$J,358.3,16343,0)
;;=N34.1^^61^772^116
;;^UTILITY(U,$J,358.3,16343,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16343,1,3,0)
;;=3^Urethritis,Nonspec
;;^UTILITY(U,$J,358.3,16343,1,4,0)
;;=4^N34.1
;;^UTILITY(U,$J,358.3,16343,2)
;;=^5015655
;;^UTILITY(U,$J,358.3,16344,0)
;;=N39.0^^61^772^120
;;^UTILITY(U,$J,358.3,16344,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16344,1,3,0)
;;=3^Urinary Tract Infection,Site Not Spec
;;^UTILITY(U,$J,358.3,16344,1,4,0)
;;=4^N39.0
;;^UTILITY(U,$J,358.3,16344,2)
;;=^124436
;;^UTILITY(U,$J,358.3,16345,0)
;;=N31.0^^61^772^81
;;^UTILITY(U,$J,358.3,16345,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16345,1,3,0)
;;=3^Neuropathic Bladder,Uninhibited NEC
;;^UTILITY(U,$J,358.3,16345,1,4,0)
;;=4^N31.0
;;^UTILITY(U,$J,358.3,16345,2)
;;=^5015644
;;^UTILITY(U,$J,358.3,16346,0)
;;=R31.9^^61^772^60
;;^UTILITY(U,$J,358.3,16346,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16346,1,3,0)
;;=3^Hematuria,Unspec
;;^UTILITY(U,$J,358.3,16346,1,4,0)
;;=4^R31.9
;;^UTILITY(U,$J,358.3,16346,2)
;;=^5019328
;;^UTILITY(U,$J,358.3,16347,0)
;;=R31.0^^61^772^57
;;^UTILITY(U,$J,358.3,16347,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16347,1,3,0)
;;=3^Hematuria,Gross
;;^UTILITY(U,$J,358.3,16347,1,4,0)
;;=4^R31.0
;;^UTILITY(U,$J,358.3,16347,2)
;;=^5019325
;;^UTILITY(U,$J,358.3,16348,0)
;;=R31.1^^61^772^56
;;^UTILITY(U,$J,358.3,16348,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16348,1,3,0)
;;=3^Hematuria,Benign Essential Microscopic
;;^UTILITY(U,$J,358.3,16348,1,4,0)
;;=4^R31.1
;;^UTILITY(U,$J,358.3,16348,2)
;;=^5019326
;;^UTILITY(U,$J,358.3,16349,0)
;;=N40.0^^61^772^3
;;^UTILITY(U,$J,358.3,16349,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16349,1,3,0)
;;=3^BPH w/o Lower Urinary Tract Symptoms
;;^UTILITY(U,$J,358.3,16349,1,4,0)
;;=4^N40.0
;;^UTILITY(U,$J,358.3,16349,2)
;;=^5015689
;;^UTILITY(U,$J,358.3,16350,0)
;;=N40.1^^61^772^2
;;^UTILITY(U,$J,358.3,16350,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16350,1,3,0)
;;=3^BPH w/ Lower Urinary Tract Symptoms
;;^UTILITY(U,$J,358.3,16350,1,4,0)
;;=4^N40.1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI108 3793 printed Nov 22, 2024@17:09:24 Page 2
IBDEI108 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16338,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,16338,1,3,0)
+4 ;;=3^Neurogenic Bladder Dysfunction,Unspec
+5 ;;^UTILITY(U,$J,358.3,16338,1,4,0)
+6 ;;=4^N31.9
+7 ;;^UTILITY(U,$J,358.3,16338,2)
+8 ;;=^5015648
+9 ;;^UTILITY(U,$J,358.3,16339,0)
+10 ;;=N31.1^^61^772^80
+11 ;;^UTILITY(U,$J,358.3,16339,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,16339,1,3,0)
+14 ;;=3^Neuropathic Bladder,Reflex NEC
+15 ;;^UTILITY(U,$J,358.3,16339,1,4,0)
+16 ;;=4^N31.1
+17 ;;^UTILITY(U,$J,358.3,16339,2)
+18 ;;=^5015645
+19 ;;^UTILITY(U,$J,358.3,16340,0)
+20 ;;=N32.89^^61^772^7
+21 ;;^UTILITY(U,$J,358.3,16340,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,16340,1,3,0)
+24 ;;=3^Bladder Disorders,Other Spec
+25 ;;^UTILITY(U,$J,358.3,16340,1,4,0)
+26 ;;=4^N32.89
+27 ;;^UTILITY(U,$J,358.3,16340,2)
+28 ;;=^87989
+29 ;;^UTILITY(U,$J,358.3,16341,0)
+30 ;;=N33.^^61^772^6
+31 ;;^UTILITY(U,$J,358.3,16341,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,16341,1,3,0)
+34 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
+35 ;;^UTILITY(U,$J,358.3,16341,1,4,0)
+36 ;;=4^N33.
+37 ;;^UTILITY(U,$J,358.3,16341,2)
+38 ;;=^5015654
+39 ;;^UTILITY(U,$J,358.3,16342,0)
+40 ;;=N34.2^^61^772^115
+41 ;;^UTILITY(U,$J,358.3,16342,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,16342,1,3,0)
+44 ;;=3^Urethritis
+45 ;;^UTILITY(U,$J,358.3,16342,1,4,0)
+46 ;;=4^N34.2
+47 ;;^UTILITY(U,$J,358.3,16342,2)
+48 ;;=^88231
+49 ;;^UTILITY(U,$J,358.3,16343,0)
+50 ;;=N34.1^^61^772^116
+51 ;;^UTILITY(U,$J,358.3,16343,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,16343,1,3,0)
+54 ;;=3^Urethritis,Nonspec
+55 ;;^UTILITY(U,$J,358.3,16343,1,4,0)
+56 ;;=4^N34.1
+57 ;;^UTILITY(U,$J,358.3,16343,2)
+58 ;;=^5015655
+59 ;;^UTILITY(U,$J,358.3,16344,0)
+60 ;;=N39.0^^61^772^120
+61 ;;^UTILITY(U,$J,358.3,16344,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,16344,1,3,0)
+64 ;;=3^Urinary Tract Infection,Site Not Spec
+65 ;;^UTILITY(U,$J,358.3,16344,1,4,0)
+66 ;;=4^N39.0
+67 ;;^UTILITY(U,$J,358.3,16344,2)
+68 ;;=^124436
+69 ;;^UTILITY(U,$J,358.3,16345,0)
+70 ;;=N31.0^^61^772^81
+71 ;;^UTILITY(U,$J,358.3,16345,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,16345,1,3,0)
+74 ;;=3^Neuropathic Bladder,Uninhibited NEC
+75 ;;^UTILITY(U,$J,358.3,16345,1,4,0)
+76 ;;=4^N31.0
+77 ;;^UTILITY(U,$J,358.3,16345,2)
+78 ;;=^5015644
+79 ;;^UTILITY(U,$J,358.3,16346,0)
+80 ;;=R31.9^^61^772^60
+81 ;;^UTILITY(U,$J,358.3,16346,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,16346,1,3,0)
+84 ;;=3^Hematuria,Unspec
+85 ;;^UTILITY(U,$J,358.3,16346,1,4,0)
+86 ;;=4^R31.9
+87 ;;^UTILITY(U,$J,358.3,16346,2)
+88 ;;=^5019328
+89 ;;^UTILITY(U,$J,358.3,16347,0)
+90 ;;=R31.0^^61^772^57
+91 ;;^UTILITY(U,$J,358.3,16347,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,16347,1,3,0)
+94 ;;=3^Hematuria,Gross
+95 ;;^UTILITY(U,$J,358.3,16347,1,4,0)
+96 ;;=4^R31.0
+97 ;;^UTILITY(U,$J,358.3,16347,2)
+98 ;;=^5019325
+99 ;;^UTILITY(U,$J,358.3,16348,0)
+100 ;;=R31.1^^61^772^56
+101 ;;^UTILITY(U,$J,358.3,16348,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,16348,1,3,0)
+104 ;;=3^Hematuria,Benign Essential Microscopic
+105 ;;^UTILITY(U,$J,358.3,16348,1,4,0)
+106 ;;=4^R31.1
+107 ;;^UTILITY(U,$J,358.3,16348,2)
+108 ;;=^5019326
+109 ;;^UTILITY(U,$J,358.3,16349,0)
+110 ;;=N40.0^^61^772^3
+111 ;;^UTILITY(U,$J,358.3,16349,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,16349,1,3,0)
+114 ;;=3^BPH w/o Lower Urinary Tract Symptoms
+115 ;;^UTILITY(U,$J,358.3,16349,1,4,0)
+116 ;;=4^N40.0
+117 ;;^UTILITY(U,$J,358.3,16349,2)
+118 ;;=^5015689
+119 ;;^UTILITY(U,$J,358.3,16350,0)
+120 ;;=N40.1^^61^772^2
+121 ;;^UTILITY(U,$J,358.3,16350,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,16350,1,3,0)
+124 ;;=3^BPH w/ Lower Urinary Tract Symptoms
+125 ;;^UTILITY(U,$J,358.3,16350,1,4,0)
+126 ;;=4^N40.1
